US FDA approves Replimune's skin cancer drug after prior rejections - Reuters
US FDA approves Replimune's skin cancer drug after prior rejections Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxQSzRDTVZPLXhNYTNDWDYyVXZTemQwOXJNQVlVblBvZHVpbUxPX0dQQzVRVTJIT2h5ZmFjVGlOZjNScjRPT1FveDliRmtNdEh5WEtNWUF4Sk5xVi1qdV9aQ3A3eEZvWHNGUDFCWGNhT0ZEb2gwdWw1amRPWkJ2d1M4em1VVVZCdUM3YW9JLXhMamVWOUFseVZnNTd3OWFwaFdWdy1VNVlITVVqUWR6dFYzZ0xFRzlGZw?oc=5" target="_blank">US FDA approves Replimune's skin cancer drug after prior rejections</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
US FDA approves Bristol Myers' blood cancer treatment - Reuters
US FDA approves Bristol Myers' blood cancer treatment Reuters
August 13, 2026 at 09:33 PMUS FDA approves Regeneron's rare bone disorder drug - Reuters
US FDA approves Regeneron's rare bone disorder drug Reuters
August 19, 2026 at 06:53 PMLawsuit against Bristol Myers over delayed cancer drug is revived - Reuters
Lawsuit against Bristol Myers over delayed cancer drug is revived Reuters
August 13, 2026 at 06:00 PMModerna shares surge as melanoma vaccine with Merck succeeds in large trial - reuters.com
Moderna shares surge as melanoma vaccine with Merck succeeds in large trial reuters.com
August 19, 2026 at 12:17 PMModerna, Merck breakthrough could usher in wave of cancer vaccines - Reuters
Moderna, Merck breakthrough could usher in wave of cancer vaccines Reuters
August 19, 2026 at 09:01 PMModerna shares double as cancer vaccine data rekindles investor hopes - Reuters
Moderna shares double as cancer vaccine data rekindles investor hopes Reuters
August 19, 2026 at 04:49 PM